OT Breast Cancer

Coverage from

2018 ASCO Annual Meeting

Focus on Breast Cancer

 

Featured Content

Breast Cancer Breakthroughs

George W. Sledge, Jr., MD, professor of Medicine and chief, Division of Oncology, Stanford University, shares his thoughts on the most recent and significant breakthroughs.

 

New! Radiotherapy Cuts BRCA-Associated Contralateral Breast Cancer Risk

Prophylactic contralateral (CLT) breast radiotherapy was associated with significantly fewer and delayed cases of breast cancer in women having standard therapy for their ipsilateral BRCA mutation-associated breast cancers in a study from Israel reported in a poster session at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

 

Read More

New! PHEREXA Trial: Analyzing Overall Survival in HER2-Positive Metastatic Breast Cancer

This phase III, randomized, two-arm study (NCT01026142) evaluated the combination of trastuzumab and capecitabine with or without pertuzumab in patients with HER2-positive metastatic breast cancer.

 

Read More

Loading